和邦生物：2025年半年度净利润约5177万元

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025 compared to the previous year [2] Financial Performance - The company's operating revenue for the first half of 2025 was approximately 3.921 billion yuan, representing a year-on-year decrease of 19.13% [2] - The net profit attributable to shareholders was about 51.77 million yuan, which is a year-on-year decrease of 73.07% [2] - Basic earnings per share were 0.0065 yuan, reflecting a year-on-year decrease of 71.86% [2]